Galbraith Kenneth bought ZYME
December 22, 2025 · Form 4 insider transaction
Galbraith Kenneth bought 100,000 shares of Zymeworks Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderGalbraith Kenneth
RoleOfficer, Director
CompanyZymeworks Inc. (ZYME)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 22, 2025
Filing dateDecember 22, 2025
Shares owned after180,803
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock issued upon vesting of restricted stock units ("RSUs") granted on December 22, 2022.